BioCentury
ARTICLE | Clinical News

RSD-921 small molecule: Will begin Phase I trials in China and Brazil in the near future.

February 20, 1996 8:00 AM UTC

Nortran Pharmaceuticals Inc., Vancouver, B.C. Product: RSD-921 small molecule Indication: Cardiac arrhythmia Status: Will begin Phase I trials in China and Brazil in the near future. The company is ne...